Management of patients with ovarian cancer in the COVID-19 era
- Bogani G.
- Casarin J.
- Pinelli C.
- Di Donato V.
- Bosio S.
- Ruisi S.
- Brusadelli C.
- Guerrisi R.
- Sarpietro G.
- Ditto A.
- Ghezzi F.
- Raspagliesi F.
DOIAbstract
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment
Add to ORKG